All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2006-004073-10 | Effect of Atomoxetine and a standardized behavior therapy on attention deficits in adult ADHD | 2009-03-06 | due-trials |
Reported results | 2007-001602-24 | Intraprostatic injection of Botulinumtoxin type A in patients with chronic prostatitis / chronic pelvic pain syndrome (CP/CPPS) | 2012-07-29 | due-trials |
Completed, but no date Terminated | 2007-007794-23 | Prospektive, doppelblinde, randomisierte, Plazebo-kontrollierte Cross-over Studie zur Wirkung von intravenösen Immunglobulinen bei komplex-regionalem Schmerzsyndrom Typ I (M. Sudeck) | bad-data | |
Reported results Terminated | 2011-000624-16 | Infertility and inflammatory urogenital diseases as a result of the metabolic syndrome Male infertility with infection and inflammation -MIBIE- Projekt B4: Infertilität und inflammatorische Urogen... | 2014-06-03 | due-trials |
Listed as ongoing, but also has a completion date | 2012-004053-88 | EuroNet-Paediatric Hodgkin’s Lymphoma Group Second International Inter-Group Study for Classical Hodgkin’s Lymphoma in Children and Adolescents Andre internasjonale studie for klassisk Hogkin ly... | 2024-10-31 | bad-data |
Completed, but no date, and reported results | 2014-000861-32 | Exploring Efficacy and Safety of oral Pirfenidone for progressive, non-IPF Lung Fibrosis (RELIEF) A randomized, double-blind, placebo-controlled, parallel group, multi-center, phase II trial Erfo... | bad-data | |
Completed, but no date | 2014-002479-28 | GM-CSF Inhalation to improve HOst defense and Pulmonary barrier rEstoration GM-CSF Inhalation zur Verbesserung der Wirtsabwehr und der Wiederherstellung der alveolären Barrierefunktion | bad-data | |
Completed, report not yet due | 2015-002835-17 | Investigation of the influence of PAH-specific medication on right ventricular function in patients with pulmonary arterial hypertension (PAH) under basal conditions Untersuchung des Einflusses PAH... | 2024-08-14 | not-yet-due |
Ongoing | 2016-000573-20 | Effects of MUTAFLOR® on exercise-induced gastro-intestinal dysfunction Effekte von MUTAFLOR® auf die belastungsinduzierte Störung der gastrointestinalen Integrität | not-yet-due | |
Other | 2020-000681-42 | Long-term need of ranibizumab injections with or without early targeted peripheral laser photocoagulation for treatment of macular edema due to central retinal vein occlusion Langzeitbedarf von Ran... | not-yet-due | |
Completed, but no date | 2020-001654-21 | Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) Inhalation to prevent ARDS in COVID-19 pneumonia Granulozyten-Monozyten-Kolonie-stimulierende Faktor (GM-CSF) Inhalation zur Verhinderun... | bad-data | |
Completed, but no date | 2022-003725-22 | Acute effect of iloprost (Ventavis®) inhalation in patients with exercise-induced pulmonary hypertension after a COVID-19 infection Akute Wirkung von Iloprost (Ventavis)®-Inhalation bei Patienten... | bad-data |